Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Targeted cancer therapies often cause serious skin problems that need careful management.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Blood vessels and specific genes help turn cartilage into bone when bones heal.

Blocking JAK-STAT signaling can lead to hair growth.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Humans lost body hair relatively recently in evolution.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The p75 neurotrophin receptor is important for hair follicle regression by controlling cell death.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Smart biomaterials that guide tissue repair are key for future medical treatments.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Some breast cancer chemotherapy can cause permanent hair loss.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.